• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Influenza Other Respir Viruses . Registry-Based Surveillance of Severe Acute Respiratory Infections in Norway During 2021-2024

tetano

Editor, Senior Moderator
Influenza Other Respir Viruses


. 2025 Feb;19(2):e70080.
doi: 10.1111/irv.70080. Registry-Based Surveillance of Severe Acute Respiratory Infections in Norway During 2021-2024

Elina Seppälä[SUP] 1 [/SUP], Håkon Bøås[SUP] 1 [/SUP], Jesper Dahl[SUP] 1 [/SUP], Jeanette Stålcrantz[SUP] 1 [/SUP], Melanie Stecher[SUP] 1 2 [/SUP], Ragnhild Tønnessen[SUP] 1 3 [/SUP], Gunnar Øyvind Isaksson Rø[SUP] 4 [/SUP], Hilde Kløvstad[SUP] 1 [/SUP], Trine Hessevik Paulsen[SUP] 1 [/SUP]



Affiliations
Abstract

Background: In 2021, the Norwegian Institute of Public Health established temporary registry-based surveillance of severe acute respiratory infections (SARI). We aimed to describe the surveillance system and evaluate selected attributes to inform the establishment of a permanent SARI surveillance system.
Methods: SARI cases were defined using ICD-10 discharge codes from national health and administrative registries, including codes for acute upper or lower respiratory infection (URI and LRI), COVID-19, acute respiratory distress syndrome, pertussis or otitis media. Data from polymerase chain reaction (PCR) analyses were available for 10 respiratory pathogens including SARS-CoV-2, influenza virus and respiratory syncytial virus (RSV). We included data from 28 September 2020 to 31 March 2024 and calculated the following parameters: the proportion of cases tested for SARS-CoV-2, influenza virus and/or RSV; time between admission and registration of a SARI-related ICD-10 code; and proportion of cases with URI, LRI and COVID-19.
Results: We identified 214,730 SARI cases, of whom 82%, 73% and 53% were tested for SARS-CoV-2, influenza virus and RSV. Case peaks were predominantly driven by one or a combination of these pathogens. Median time between admission and a registered SARI diagnostic code was 5 (lower-upper quartile 3-10) days. Nowcasting and alternative case definitions for SARI with COVID-19, influenza and RSV improved the timeliness. The ICD-10 codes for LRIs and COVID-19 captured only ~55% of the cases in the age group of 0-29 years compared to the routine case definition, where URIs were included.
Conclusions: Registry-based SARI surveillance provides timely data for handling epidemics of respiratory infections in Norway. We recommend establishing a permanent SARI surveillance system.

Keywords: COVID‐19; RSV; hospitalisation; influenza; registry‐based surveillance; severe acute respiratory infection (SARI).

 
Back
Top Bottom